Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company focused on cardiometabolic conditions, including type 2 diabetes and hypertension. The company went public through a de-SPAC merger with Mountain Crest Acquisition Corp. II, a blank-check vehicle sponsored by Mountain Crest Capital LLC that completed its IPO in 2021. The combined entity trades under the BTTX ticker on Nasdaq and operates in the digital health and therapeutics sector, developing software-based interventions designed to address the root behavioral causes of chronic disease. The filing in view is an amended quarterly report on Form 10-Q/A, submitted to the SEC on June 28, 2021, under accession number 0001104659-21-085909. For the full filing history, deal terms, sponsor background, and real-time SPAC analytics on BTTX, sign up for complete access at SpacDesk.